HIF1A and liver dysplastic nodule: As for DN, in an animal model of type 1 DN [150], OVE26, HIF-1α inhibitor, attenuated kidney glomerular hypertrophy, mesangial matrix expansion, extracellular matrix accumulation, and urinary albumin excretion.